EP Patent

EP2285348A1 — Opioid composition for treating skin lesions

Assigned to Euro Celtique SA · Expires 2011-02-23 · 15y expired

What this patent protects

The present invention relates to a composition, comprising (i) a matrix made of polymeric nanofϊbers, and (ii) an opioid agonist within the matrix.

USPTO Abstract

The present invention relates to a composition, comprising (i) a matrix made of polymeric nanofϊbers, and (ii) an opioid agonist within the matrix.

Drugs covered by this patent

chembl-chembl2103744 (MORPHINE SULFATE)

Patent Metadata

Patent number: EP2285348A1
Jurisdiction: EP
Classification: —
Expires: 2011-02-23
Drug substance claim: No
Drug product claim: No
Assignee: Euro Celtique SA
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.